Skip to main content
Observe Medical logo

Observe Medical — Investor Relations & Filings

Ticker · OBSRV ISIN · NO0010865009 LEI · 9845005F38B74FFJ1B65 Euronext Expand Manufacturing
Open in API
Filings indexed 641 across all filing types
Latest filing 2025-08-21 Regulatory Filings
Country NO Norway
Listing Euronext Expand OBSRV

About Observe Medical

https://observemedical.com/

Observe Medical is a medical technology company that develops, markets, and sells innovative medtech products for the global market. The company is committed to improving patient welfare and outcomes, increasing clinical data accuracy, and promoting positive health economics. It is building a scalable medtech platform that combines a portfolio of proprietary products with strategic partnerships, leveraging its manufacturing, development, regulatory, and commercial capabilities to bring new technologies to market.

Recent filings

Filing Released Lang Actions
Observe Medical has seen successful customer conversions in Switzerland and Slovenia and receives additional orders
Regulatory Filings Classification · 100% confidence The document is a short press release announcing new commercial orders and successful product conversions in Switzerland and Slovenia. It does not contain financial statements, regulatory filings, or specific corporate governance disclosures. As it is a general corporate announcement regarding business operations that does not fit into the specific categories like M&A, dividends, or earnings releases, it falls under the general regulatory announcement category.
2025-08-21 English
OBSERVE MEDICAL ASA: Mandatory notification of trade - grant of share options to primary insiders - Attachment: Release.pdf
Remuneration Information Classification · 99% confidence The document is titled "OBSERVE MEDICAL ASA: Mandatory notification of trade – grant of share options to primary insiders". It details the granting of share options to the CEO and CFO (primary insiders) and references disclosure requirements under Article 19 of EU Regulation 596/2014 (MAR) and Norwegian Securities Trading Act. This type of mandatory disclosure concerning personal share transactions by directors and executives directly maps to the definition of Director's Dealing (DIRS). Although it involves options rather than direct share purchases/sales, in the context of insider transaction reporting, it falls under this category, distinct from general capital changes (CAP/SHA) or remuneration reports (DEF 14A).
2025-07-22 English
OBSERVE MEDICAL ASA: Mandatory notification of trade - grant of share options to primary insiders
Remuneration Information Classification · 99% confidence The document is a mandatory notification regarding the grant of share options to primary insiders (CEO and CFO) of Observe Medical ASA. This type of transaction report, detailing personal share dealings by directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it mentions attached forms for mandatory notifications, the core content is the insider trade disclosure itself, which is more specific than a general Regulatory Filing (RNS) or Report Publication Announcement (RPA). It is not a general announcement of a dividend (DIV), capital change (SHA), or a general earnings release (ER).
2025-07-22 English
Observe Medical receives first UnoMeter[TM] Safeti[TM] Plus orders from key Central and South American markets, representing 75% of the historic sales in the region - Attachment: Release.pdf
Regulatory Filings Classification · 100% confidence The document is a short press release dated July 11, 2025, announcing that Observe Medical has received new orders for its UnoMeterTM SafetiTM Plus product from distributors in Argentina and Central American countries. It highlights market potential and includes CEO commentary. This type of announcement, focusing on specific business developments, sales achievements, or operational news that doesn't fit a standard financial report (like 10-K, ER, or IR), is best classified as a general Regulatory Filing (RNS) or potentially a miscellaneous announcement. Given the options, RNS serves as the best general regulatory/news announcement category for non-standard, material business updates that are not explicitly defined elsewhere (like DIRS, DIV, or CAP). It is too brief and specific to be an Earnings Release (ER) or Interim Report (IR).
2025-07-11 English
Observe Medical receives first UnoMeter[TM] Safeti[TM] Plus orders from key Central and South American markets, representing 75% of the historic sales in the region
Regulatory Filings Classification · 99% confidence The document is a short press release dated July 11, 2025, announcing that Observe Medical has received new orders for its UnoMeter™ Safeti™ Plus product from distributors in Central and South American markets. It includes commentary from the CEO and contact information. This type of announcement, detailing specific business developments, sales achievements, or operational news that is not a full financial report (like 10-K or IR) or a formal regulatory filing like a major shareholding change (MRQ) or director dealing (DIRS), typically falls under a general regulatory announcement or news release category. Since there is no specific category for 'Business Update' or 'Sales Announcement', and given its brevity and nature as a market-moving news item, it best fits the 'Regulatory Filings' (RNS) category, which serves as a general regulatory announcement fallback for non-standard filings.
2025-07-11 English
Observe Medical ASA: Registration of new share capital
Share Issue/Capital Change Classification · 99% confidence The document is titled "Observe Medical ASA: Registration of new share capital" and explicitly states that the share capital increase pertaining to newly issued shares (from a private placement and loan conversion) has been registered with the Norwegian Register of Business Enterprises. This action directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for Capital/Financing Update (CAP), which covers updates on fundraising, financing activities, or capital structure changes. Although it involves shares, it is a registration update following a financing event, rather than a general share issue announcement (SHA) or a buyback (POS). Given the context of a private placement and subsequent registration, CAP is the most precise fit.
2025-07-09 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.